BIOS raises $4.5M to further develop its ‘neural interface’ and new ways to treat chronic medical conditions
Publication/Creation DateDecember 4 2018
DescriptionBIOS, a neural engineering startup originally based out of Cambridge, U.K. and now with an additional newly opened R&D office in Montreal, Canada, has raised $4.5 million in seed funding. The company is developing a “neural interface” that combines advances in hardware, big data and machine learning/AI, which it’s hoped can be used to develop new cutting-edge treatments on organs and nerve systems throughout the body.
Date archivedApril 15 2019
Last editedMay 1 2019